| 摘要 |
<p>The present invention comprises a stable and non-toxic coenzyme Q10 formulation with superior bioavailability suitable for oral administration to an animal or a human to rapidly produce clinically effective blood levels of coenzyme Q10. Clinically effective blood levels of coenzyme Q10 are generally agreed to be between about 2 νg/mL and about 4 νg/mL. The formulation consists of saturated vegetable oil, hydrogenated vegetable oil or animal fat as a vehicle in which coenzyme Q10 is dissolved. The formulation preferably contains coenzyme Q10 at a level of about 100 mg to about 150 mg dissolved in about 350 νL to about 500 νL of saturated vegetable oil, hydrogenated vegetable oil or animal fat enclosed in a gelatin capsule. The clinically accepted vegetable oil is saturated, preferably coconut oil.</p> |
